Latest news
Satellite Bio Wins FDA IND Clearance for SB-101, Marking Transition to Clinical-Stage Company - BioPharm InternationalBioPharm International · Wed, 05 Aug 2026 16:02:37 GMTSatellite Bio wins FDA IND clearance for off-the-shelf liver cell therapy SB-101 in urea cycle disorders - DealroomDealroom · Wed, 05 Aug 2026 12:51:58 GMTSatellite Bio Announces FDA Clearance of IND Application for SB-101 for the Treatment of Urea Cycle Disorders (UCDs) Marking its Transition to a Clinical-Stage Biotechnology Company - BioSpaceBioSpace · Wed, 05 Aug 2026 03:09:09 GMT